Harmony Biosciences Holdings, Inc. (HRMY) › Operating Cash FlowHarmony Biosciences Holdings, Inc. (HRMY) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$75.44M2020: -$2.98M2021: $98.56M2022: $144.47M2023: $219.39M2024: $219.82M2025: $348.20M$348.20M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$348.20M+58.4%2024$219.82M+0.2%2023$219.39M+51.9%2022$144.47M+46.6%2021$98.56M+3401.7%2020-$2.98M+96.0%2019-$75.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share